224 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
SCIENTIFIC PROGRAMME
216
› Thursday, 12 October 2017
ST-27 (d)
State-of-the-Art-Symposium
08:15–09:45
|
Hall A6 /A7
TOPIC 7:
Personality disorders
Ätiologie und Behandlung der Persönlichkeits-
störungen
Chairs:
Sabine C. Herpertz, Germany
Peter Fiedler, Germany
001
Funktionsbeeinträchtigungen als Targets
modularer Psychotherapie
Sabine C. Herpertz, Germany
002
Die Bedeutung der Komorbiditätsforschung
für die Behandlungsplanung
Peter Fiedler, Germany
S-339
Symposium
08:15–09:45
|
Hall A8
TOPIC 35:
Psychiatry and society
The identity of psychiatry – evolving challenges
Chairs:
Henning Saß, Germany
Helen Herrman, Australia
001
Psychiatry: the person and its brain (part I)
Wolfgang Maier, Germany
002
Psychiatry: the person and its brain (part II)
Henning Saß, Germany
003
From mental illness to mental health
Helen Herrman, Australia
004
What makes a good psychiatrist
Dinesh Bhugra, United Kingdom
005
21st century psychiatry: acknowledging
complexity while avoiding defeatism
Mario Maj, Italy
S-340
Symposium
08:15–09:45
|
Hall A3
TOPIC 23:
Health care research and models, health care
policy
Professionals and politicians – interactions to
improve psychiatric services in Germany
Chairs:
Arno Deister, Germany
Iris Hauth, Germany
001
Psychiatric services – major problems ahead
Andreas Heinz, Germany
002
Optimal care needs adequate remuneration:
the Psych-Entgeltgesetz and its implications
Arno Deister, Germany
003
Aligning forces to improve mental health care
services: „Plattform Entgelt“and its fight against
PEPP
Iris Hauth, Germany
004
Aktion Psychisch Kranke: ongoing consulta-
tions with federal politics in favour of patients and
relatives
Heinrich Kunze, Germany
S-341
Symposium
08:15–09:45
|
Hall A5
TOPIC 44:
Other topics
Implementing culturally sensitive psychiatric
diagnostics in the Nordic countries
Chairs:
Roberto Lewis-Fernandez, USA
Sigrid Helene Haug, Norway
001
Evaluating clinical use in Sweden of the DSM-5
Cultural Formulation Interview
Sofie Bäärnhielm, Sweden
002
Evaluating feasibility and clinical utility of the
DSM-5 Cultural Formulation Interview in complex
rehabilitation treatment
Valerie Demarinis, Sweden
Sigrid Helene Haug
003
Implementation of Cultural Formulation Inter-
view in Norway – aim and scope with an emphasis
on its recovery-oriented properties
Sigrid Helene Haug, Norway
004
The use of the Cultural Formulation Interview
in Denmark
Signe Skammeritz, Denmark
S-342
Symposium
08:15–09:45
|
Hall A2
TOPIC 3:
Psychotic disorders
Dealing with schizophrenia today
›
WPA Section: Schizophrenia
Chairs:
Wolfgang Gaebel, Germany
Veronica Larach Walters, Chile
001
Designing policies for schizophrenia:
what to consider?
Wolfgang Gaebel, Germany
002
Using existing health resources to provide
universal coverage for schizophrenia: GES initiative
in Chile
Veronica Larach Walters, Chile
Luis Varela, Irma Rojas, Guillermo Vergara